BrightPath BiotherapeuticsLtd. (4594.TSE) Q2 2026 Earnings

14MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-4.42
-3.62
-2.83
-2.03

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

BrightPath BiotherapeuticsLtd. (4594.TSE) will report earnings of for Q2 2026 on May 14, 2026.

0 Comments

Share your thoughts